Alkyl Amines Chemicals Limited

NSE:ALKYLAMINE.NS

2367.05 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 14,406.116,823.315,236.0612,231.1869,730.4958,322.1856,050.0144,886.2454,726.0794,679.8014,402.8653,589.6582,880.0972,326.7872,150.0721,969.3031,585.4041,313.549
Cost of Revenue 9,216.38,596.78,533.7795,364.6764,954.1744,723.8093,421.2382,728.8262,604.6232,685.5912,503.2342,093.0911,565.0341,788.7511,622.8361,489.0541,372.9551,119.751
Gross Profit 5,189.88,226.66,702.2816,866.514,776.3213,598.3762,628.7762,157.4192,121.4561,994.211,899.6311,496.5671,315.063538.036527.236480.249212.449193.798
Gross Profit Ratio 0.360.4890.440.5610.4910.4320.4350.4420.4490.4260.4310.4170.4570.2310.2450.2440.1340.148
Reseach & Development Expenses 77.83466.88156.63348.47442.04833.97844.75448.86942.42442.62440.2833.606020.239.684000
General & Administrative Expenses 80.18681.41569.27655.55354.21330.6277.7516.647.0388.78.7197.481000000
Selling & Marketing Expenses 472.731737.616524.195273.991224.879175.047126.61884.53677.05854.15479.17443.405738.332115.57892.688000
SG&A 3,271.6819.031593.471329.544279.092205.674134.36991.17684.09662.8548.7197.481738.332115.57892.688000
Other Expenses 150.5139.19.0871.5620.7774.8832.450.4020.5060.0763.3872.928226.622157.315128.16279.6055.0234.209
Operating Expenses 3,271.65,246.93,776.0192,808.652,462.312,176.0141,594.9661,367.2281,280.7311,215.3621,135.2191,007.921964.954293.123230.532279.6055.0234.209
Operating Income 1,918.23,028.7322,921.1654,012.3432,316.9761,422.3621,033.81790.191726.216671.952650.527361.255350.109244.913296.704200.644207.426189.589
Operating Income Ratio 0.1330.180.1920.3280.2380.1710.1710.1620.1540.1440.1480.1010.1220.1050.1380.1020.1310.144
Total Other Income Expenses Net 106.556.85599.982-5.414280.117-96.82-58.962-60.931-115.559-91.535-111.175-122.492-110.279-103.226-120.392-117.143-79.042-75.585
Income Before Tax 2,024.73,085.63,021.1474,006.9292,457.5141,325.542974.848729.26726.216671.952650.527361.255239.83141.687176.31283.501128.384114.004
Income Before Tax Ratio 0.1410.1830.1980.3280.2530.1590.1610.1490.1540.1440.1480.1010.0830.0610.0820.0420.0810.087
Income Tax Expense 536799772.1821,053.518444.281464.504314.846232.256226.595215.751217.435119.96265.18738.01558.87642.19441.50831.264
Net Income 1,488.7312,286.5532,248.9652,953.4112,152.812861.038660.002510.023500.377451.348432.745242.127175.949139.556117.43641.30786.87682.74
Net Income Ratio 0.1030.1360.1480.2410.2210.1030.1090.1040.1060.0960.0980.0670.0610.060.0550.0210.0550.063
EPS 29.1344.7544.0457.8742.2216.8912.9410.169.814.434.244.753.452.742.30.811.81.82
EPS Diluted 29.0944.6843.9557.7242.1116.8912.9410.169.814.434.244.753.452.742.30.811.71.58
EBITDA 2,507.43,570.53,387.7174,389.6282,651.5791,689.5141,212.864914.261949.552887.266857.864567.977439.203336.591383.399270.349270.337250.734
EBITDA Ratio 0.1740.2120.2220.3590.2730.2030.20.1870.2010.190.1950.1580.1520.1450.1780.1370.1710.191